HOME - News - Editorials
 
 
17 October 2025

Cruz-Almeida Director of UFCD CTR


Yenisel Cruz-Almeida, Ph.D., has been appointed the director of Clinical and Translational Research for the University of Florida College of Dentistry, or UFCD. 

Cruz-Almeida, a professor in the UF Department of Community Dentistry & Behavioral Science, and associate director of the UF Pain Research and Intervention Center of Excellence, also has appointments in the UF College of Medicine’s Department of Neuroscience and the UF College of Public Health & Health Professions’ Department of Epidemiology. 

In her new role as director of Clinical and Translational Research, or CTR, she is providing direction and supporting initiatives elevating UFCD’s translational research agenda, building interdisciplinary teams and strategic partnerships to accelerate bench-to-bedside innovation that advances patient outcomes and shapes the future of personalized healthcare.

“Dr. Cruz-Almeida has multidisciplinary expertise spanning preclinical and clinical research, epidemiology and neuroscience. This knowledge base gives her a unique ability to build a transformative research framework that bridges the continuum from discovery to clinical application, that advances patient outcomes and inform precision care,” said A. Isabel Garcia, UFCD dean. 

Cruz-Almeida will coordinate her efforts with UFCD leadership in research and in planning and institutional effectiveness, to ensure that the college’s translational research supports all areas of the college missions, and strategic plans and initiatives. 

Cruz-Almeida earned her bachelor’s in microbiology and cell science from UF in 2001, her master’s in epidemiology and public health with a concentration in biostatistics in 2004, and her doctorate in neuroscience in 2011, both from the University of Miami.

Cruz-Almeida is a clinical translational neuroscientist specializing in pain mechanisms across the lifespan. Using psychophysics, neuroimaging and epigenetics, she identifies nervous system factors underlying individual pain variability and functional outcomes. Her approach bridges basic neuroscience, clinical outcomes, and population health—uniquely positioning her to lead UFCD’s translational research enterprise.


Source: https://dental.ufl.edu/

Related articles

HSDM director of admissions reflects on the rewarding aspects of her work as she is recognized for her contributions to HSDM


The board of directors of Colgate-Palmolive Company (NYSE:CL) recently announced an increase in the quarterly common stock cash dividend to $0.53 up from $0.52 per share.


Dr. Todd Gray, passion, for oral healthcare aligns with Sun Life and TeamSmile missions to provide children in need with life-changing dental care


Georgia School of Orthodontics (GSO) announced the appointment of Mohamed I. Masoud, BDS, DMSc, a Diplomate of the American Board of Orthodontics, as its new Director of Research. A distinguished...


Parkview Dental, a leading Dental Support Organization committed to providing comprehensive management services to dental practices, announced the appointment of Lisa Burris as its new Director of...


Read more

Patient perception research has failed to focus on burgeoning technology within the dental field.


Some admissions experiences can make an applicant feel like a statistic being analyzed or, as first-year Florida dental student Nate Fordham put it, like a “mushroom”: kept in the dark and fed...


Streamline your workflow with BioHorizons. Tapered Pro Conical offers a single, color-coded prosthetic platform for all full-arch cases.


Following AI Voice Perio, voice-driven charting expands to restorative exams, enabling single-provider clinical documentation in Denticon.


Cosmetic & Reconstructive Dentistry recently announced the creation of a new scholarship program supporting graduating seniors from Fairfield’s public high schools who plan to pursue studies in...


 
 
 
 

 
 
 
 

Most popular

 
 

Events